Skip to main content
OpenTrials

Clinical trial condition

Neovascular Age-related Macular Degeneration

Explore clinical trials studying Neovascular Age-related Macular Degeneration. Study availability and eligibility vary by location and protocol.

149 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Neovascular Age-related Macular Degeneration trial results

Recruiting

A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD

NCT06847542

Conditions
Neovascular Age-related Macular Degeneration
Locations
  • Medizinische Universität Innsbruck Innsbruck, Austria
  • Kepler Universitätskliniken GmbH - Med Campus III Linz, Austria
  • Landesklinikum Mistelbach Mistelbach, Austria
  • Klaudianova Nemocnice - Mlada Boleslav;Ophtalmology dpt Mladá Boleslav, Czechia
View all 61 locations
View Trial Details
Recruiting

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

NCT07614776

Conditions
Neovascular Age-related Macular Degeneration, nAMD
Locations
  • Retina Consultants of Orange County Fullerton, California, United States
  • South Coast Retina Center - RCA Long Beach, California, United States
  • Retinal Consultants Medical Group, Inc.-Sacramento, Greenback Lane, (RCA) Modesto, California, United States
  • California Eye Specialists Medical Group, Inc Pasadena, California, United States
View all 64 locations
View Trial Details
Recruiting

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

NCT07007065

Conditions
Neovascular Age-related Macular Degeneration
Locations
  • Barnet Dulaney Perkins Eye Centers /ID# 279265 Mesa, Arizona, United States
  • American Vision Partners /ID# 264615 Sun City, Arizona, United States
  • Retinal Diagnostic Center /ID# 263054 Campbell, California, United States
  • The Retina Partners /ID# 263265 Encino, California, United States
View all 133 locations
View Trial Details
Recruiting

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

NCT04853251

Conditions
Neovascular Age-related Macular Degeneration
Locations
  • Barnet Dulaney Perkins Eye Center Mesa, Arizona, United States
  • California Retina Consultants Bakersfield, California, United States
  • Retina Associates of Southern California Huntington Beach, California, United States
  • California Eye Specialists Medical group Inc. Pasadena, California, United States
View all 52 locations
View Trial Details
Recruiting

Extension Study for the Port Delivery System With Ranibizumab (Portal)

NCT03683251

Conditions
Neovascular Age-related Macular Degeneration
Locations
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Arizona Retina and Vitreous Consultants Phoenix, Arizona, United States
  • Barnet Dulaney Perkins Eye Center Phoenix, Arizona, United States
  • Associated Retina Consultants Phoenix, Arizona, United States
View all 165 locations
View Trial Details
Recruiting

Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

NCT05986864

Conditions
Neovascular Age-related Macular Degeneration
Locations
  • Retina Vitreous Associates of Florida - Saint Petersburg St. Petersburg, Florida, United States
  • Ophthalmic Consultants of Boston Boston, Massachusetts, United States
  • Retina Consultants of Texas Katy, Texas, United States
  • Wagner Kapoor Research Institute Norfolk, Virginia, United States
View Trial Details
Recruiting

Regulatory Post-Marketing Surveillance Study for Brolucizumab

NCT04985487

Conditions
Neovascular Age-related Macular Degeneration
Locations
  • Novartis Investigative Site Daegu, Dalseo Gu, South Korea
  • Novartis Investigative Site Goyang-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Guri-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Suwon, Gyeonggi-do, South Korea
View all 28 locations
View Trial Details

Related conditions